FDA Inspection 965172 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 1718889

The FDA completed an inspection of Biomat USA, Inc. on Sep 3, 2015 in Colorado Springs, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 3, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Colorado Springs, CO (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
923621 CFR 630.40(b)(1)Deferred or not eligible